Latest filing published 23 Mar 2026 for iBio, Inc., €22k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -16.3%Entry US$2.08 · Close at T+90 US$1.74
- -8.8%Entry US$2.73 · Close at T+365 US$2.49
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Martin Brenner: trading record in brief
This profile gathers the share dealings of Martin Brenner in iBio, Inc. Between 11 November 2022 and 19 March 2026, the trades on record add up to 22 filings.
Market trades split into 2 purchases (€46k) and 15 sales (€60k). Sales outweigh purchases by €14k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants. In 2026 alone, the filings show 1 purchase and no sales.
The newest entry dates from 23 March 2026: an open-market purchase of €22k, in iBio, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Martin Brenner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,336 shares@ US$2.0220.6% of flowCommon StockSEC:0001104659-26-033021:0Canonical exit: 17 Jun 2026 (T+90)
- 9,191 shares@ US$2.7223.0% of flowCommon StockSEC:0001104659-25-003063:0Canonical exit: 10 Apr 2025 (T+90)
- 4,881 shares@ US$0.26551.2% of flowCommon StockSEC:0001104659-23-114269:0
- 5,267 shares@ US$0.30221.4% of flowCommon StockSEC:0001104659-23-107157:0
- 4,215 shares@ US$0.3111.2% of flowCommon StockSEC:0001104659-23-106379:0
- 5,011 shares@ US$0.30511.3% of flowCommon StockSEC:0001104659-23-096877:0
- 4,480 shares@ US$0.51112.0% of flowCommon StockSEC:0001104659-23-085306:0
- 47,020 shares@ US$0.585323.4% of flowCommon StockSEC:0001104659-23-080733:0
- 75,833 shares0Common StockSEC:0001104659-23-075015:0
- 75,833 shares0Common StockSEC:0001104659-23-075015:1
- 3,859 shares@ US$0.68052.3% of flowCommon StockSEC:0001104659-23-073578:0
- 4,158 shares@ US$0.9353.4% of flowCommon StockSEC:0001104659-23-063805:0
- 4,382 shares@ US$1.19984.5% of flowCommon StockSEC:0001104659-23-048952:0
- 50,000 shares0Common StockSEC:0001104659-23-040819:0
- 5,213 shares@ US$2.13159.7% of flowCommon StockSEC:0001104659-23-037424:0
- 3,976 shares@ US$1.776.2% of flowCommon StockSEC:0001104659-23-024785:0
- 130,000 shares0Common StockSEC:0001104659-23-006184:0
- 95,348 shares0Common StockSEC:0001104659-22-118976:0
18 of 18 declarations